Medscape2d
Relapsing-Remitting Multiple Sclerosis
Dr Pavan Bhargava shares AAN 2025 highlights, including anticipated presentations, quick takeaways, and insights into how new ...
Medscape2d
AAN 2025: Previewing New Data in the Management of Relapsing-Remitting Multiple Sclerosis
Dr Pavan Bhargava anticipates updates on diagnostic criteria, MRI techniques, biomarkers, treatments, and the role of diet in ...
High‑dose vitamin D significantly reduces disease activity in early multiple sclerosis onset, clinical trial finds
Researchers from CHU Nîmes, Université Montpellier, and multiple MS centers in France have found that oral cholecalciferol in ...
PsyPost on MSN2d
Can ibogaine repair brain damage in multiple sclerosis? New case reports spark interest
In a recent case report published in Frontiers in Immunology, scientists in Canada described how an experimental treatment ...
European Medical Journal10d
Hidden Cognitive Decline in MS: A New Concern
A new study finds that cognitive decline in relapsing-remitting multiple sclerosis (RRMS) often occurs independently of ...
MedPage Today6d
In Patients with Multiple Sclerosis, Resistance Training May Help Walking Speed
the extent of microstructural damage in patients with early relapsing-remitting multiple sclerosis (RRMS) was associated with worse disability and spinal cord atrophy at 5 years. Here are the ...
The Peninsula Qatar9h
Vitamin D3 reduces multiple sclerosis activity in early stage patients
Paris: A French study has revealed that taking vitamin D3 (cholecalciferol) orally at a dose of 100,000 international units ...
KGUN 94d
'A diagnosis is not a death sentence': Multiple Sclerosis Awareness Month
Awareness Month, 34-year-old Tucsonan Tiffany Hemmer is shedding light on her disease and why it’s important to talk about.
pharmaphorum1d
FDA starts review of Sanofi's MS hope tolebrutinib
The FDA review – which is due to be completed by 28th September – revolves around the results of the HERCULES trial which ...